Tandem Diabetes Care (TNDM) Cash & Equivalents (2013 - 2026)
Tandem Diabetes Care posted quarterly Cash & Equivalents of $179.3 million for Q1 2026, up 234.72% year-on-year from $53.6 million in Q1 2025, and up 97.86% on a QoQ basis from $90.6 million in Q4 2025.
Tandem Diabetes Care (TNDM) has 14 years of Cash & Equivalents data on file, last reported at $179.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents rose 234.72% year-over-year to $179.3 million; the trailing twelve-month figure through Mar 2026 stood at $179.3 million (up 234.72% YoY), and the FY2025 full-year result was $90.6 million, up 30.91% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $179.3 million, up from $90.6 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $179.3 million in Q1 2026 and bottomed at $47.7 million in Q2 2024.
- The 5-year median for Cash & Equivalents is $90.6 million (2025), against an average of $94.5 million.
- The widest annual swing landed in 2023, when Cash & Equivalents slumped 65.88%; it then surged 234.72% in 2026.
- A 5-year view of Cash & Equivalents shows it stood at $172.5 million in 2022, then plunged by 65.88% to $58.9 million in 2023, then climbed by 17.61% to $69.2 million in 2024, then jumped by 30.91% to $90.6 million in 2025, then soared by 97.86% to $179.3 million in 2026.
- The last three Cash & Equivalents figures came in at $179.3 million (Q1 2026), $90.6 million (Q4 2025), and $91.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | 179.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179.33 Mn |
| Dec 31, 2025 | 90.63 Mn |
| Sep 30, 2025 | 91.95 Mn |
| Jun 30, 2025 | 64.11 Mn |
| Mar 31, 2025 | 53.57 Mn |
| Dec 31, 2024 | 69.23 Mn |
| Sep 30, 2024 | 49.04 Mn |
| Jun 30, 2024 | 47.70 Mn |
| Mar 31, 2024 | 58.98 Mn |
| Dec 31, 2023 | 58.87 Mn |
| Sep 30, 2023 | 79.61 Mn |
| Jun 30, 2023 | 130.75 Mn |
| Mar 31, 2023 | 127.76 Mn |
| Dec 31, 2022 | 172.52 Mn |
| Sep 30, 2022 | 123.79 Mn |
| Jun 30, 2022 | 114.97 Mn |
| Mar 31, 2022 | 93.68 Mn |
| Dec 31, 2021 | 71.18 Mn |
| Sep 30, 2021 | 112.38 Mn |
| Jun 30, 2021 | 98.58 Mn |
| Mar 31, 2021 | 120.79 Mn |
| Dec 31, 2020 | 94.61 Mn |
| Sep 30, 2020 | 129.48 Mn |
| Jun 30, 2020 | 222.48 Mn |
| Mar 31, 2020 | 74.49 Mn |
| Dec 31, 2019 | 51.18 Mn |
| Sep 30, 2019 | 46.06 Mn |
| Jun 30, 2019 | 38.16 Mn |
| Mar 31, 2019 | 40.45 Mn |
| Dec 31, 2018 | 41.83 Mn |
| Sep 30, 2018 | 113.60 Mn |
| Jun 30, 2018 | 50.55 Mn |
| Mar 31, 2018 | 62.58 Mn |
| Dec 31, 2017 | 13.70 Mn |
| Sep 30, 2017 | 16.99 Mn |
| Jun 30, 2017 | 27.35 Mn |
| Mar 31, 2017 | 30.88 Mn |
| Dec 31, 2016 | 2.00 Mn |
| Sep 30, 2016 | 17.96 Mn |
| Jun 30, 2016 | 30.25 Mn |
| Mar 31, 2016 | 40.61 Mn |
| Dec 31, 2015 | 43.09 Mn |
| Sep 30, 2015 | 43.21 Mn |
| Jun 30, 2015 | 45.92 Mn |
| Mar 31, 2015 | 62.55 Mn |
| Dec 31, 2014 | 31.18 Mn |
| Sep 30, 2014 | 35.56 Mn |
| Jun 30, 2014 | 64.21 Mn |
| Mar 31, 2014 | 76.83 Mn |
| Dec 31, 2013 | 124.39 Mn |
| Sep 30, 2013 | 15.55 Mn |
| Jun 30, 2013 | 30.13 Mn |
| Mar 31, 2013 | 29.44 Mn |